Clinical classification of polycystic ovary syndrome

被引:0
|
作者
Krause, J [1 ]
Karasu, T [1 ]
Grunwald, K [1 ]
Neulen, J [1 ]
机构
[1] Rhein Westfal TH Aachen, Univ Frauenklin Gynakol Endokrinol & Reprod Med, D-52074 Aachen, Germany
来源
GYNAKOLOGE | 2002年 / 35卷 / 01期
关键词
polycystic ovary syndrome; PCO syndrome; hyperandrogenemia; metabolic syndrome;
D O I
10.1007/PL00003301
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The definition of polycystic ovary syndrome is still subject to debate. Ultrasonographic diagnosis alone does not suffice. Clinical relevance is only reached when additional endocrinological alterations exist such as irregular menstrual cycles, hyperandrogenemia, or a disorder of glucose metabolism. An endocrinological work-up is thus indispensable. The pathophysiological associations are still not completely clarified so that primarily ovarian as well as disturbances of different hormonal systems can be present. It appears that various factors such as an elevation of testosterone or even insulin levels lead to an increase of LH concentrations and thus to hyperandrogenemia. Only when the cause has been determined adequate therapy can be instituted. Special attention should be paid to possible insulin resistance or metabolic syndrome because of the harmful cardiovascular after-effects.
引用
收藏
页码:64 / 68
页数:5
相关论文
共 50 条
  • [1] Ethnicity in polycystic ovary syndrome
    Shah, D.
    Rasool, S.
    CLIMACTERIC, 2023, 26 (01) : 15 - 20
  • [2] Quercetin and polycystic ovary syndrome
    Ma, Congshun
    Xiang, Qianru
    Song, Ge
    Wang, Xuefei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] Syndrom der polyzystischen Ovarien: Klinische EinteilungClinical classification of polycystic ovary syndrome
    J. Krause
    T. Karasu
    K. Grunwald
    J. Neulen
    Der Gynäkologe, 2002, 35 (1): : 64 - 68
  • [4] Proposal on the diagnosis and classification of polycystic ovary syndrome
    俞瑾
    生殖医学杂志, 2007, (S1) : 1 - 3
  • [5] Towards a rational classification of polycystic ovary syndrome
    Doi, Suhail A. R.
    Al-Shoumer, Kamal A. S.
    SALUD I CIENCIA, 2009, 16 (07): : 769 - 773
  • [6] Clinical Observation of Polycystic Ovary Syndrome Treatment with Resveratrol
    Wang, Fang
    Zheng, Y.
    Yuan, Huiqin
    Dong, Qiyin
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 272 - 277
  • [7] Obesity and Hyperandrogenemia in Polycystic Ovary Syndrome: Clinical Implications
    Lopez-Alarcon, Mardia
    Vital-Reyes, Victor Saul
    Almeida-Gutierrez, Eduardo
    Maldonado-Hernandez, Jorge
    Flores-Chavez, Salvador
    Dominguez-Salgado, Juan Manuel
    Vite-Bautista, Jose
    Cruz-Martinez, David
    Barradas-Vazquez, Aly S.
    Z'Cruz-Lopez, Ricardo
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (09):
  • [8] Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?
    Shah, D.
    Rasool, S.
    CLIMACTERIC, 2016, 19 (01) : 7 - 16
  • [9] Effect of aging on clinical features and metabolic complications of women with polycystic ovary syndrome
    Falcetta, P.
    Benelli, E.
    Molinaro, A.
    Di Cosmo, C.
    Bagattini, B.
    Del Ghianda, S.
    Salvetti, G.
    Fiore, E.
    Pucci, E.
    Fruzzetti, F.
    Tonacchera, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (12) : 2725 - 2733
  • [10] Acupuncture in polycystic ovary syndrome: Current experimental and clinical evidence
    Stener-Victorin, E.
    Jedel, E.
    Manneras, L.
    JOURNAL OF NEUROENDOCRINOLOGY, 2008, 20 (03) : 290 - 298